USFDA grants orphan drug and pediatric exclusivities for Cresemba for aspergillosis and mucormycosis in children
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Launch innovative vitamin sublingual sprays
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Subscribe To Our Newsletter & Stay Updated